Remove 12
article thumbnail

Redefining clinical trials: Adopting AI for speed, volume and diversity

IBM Big Data Hub

In 2022, less than 10% of trial participants for FDA approval were Black, fewer than 12% were Asian, under 13% were Hispanic, and women constituted less than 50% (Exhibit 3), not reflective of the current US population. The FDA’s 2020 guidance emphasized expanding eligibility criteria and reducing unnecessary exclusions.

article thumbnail

The Belgian Data Protection Authority Publishes Recommendation Concerning Data Processing for Direct Marketing Purposes

HL Chronicle of Data Protection

On January 17, The Belgian Data Protection Authority (DPA) published Recommendation no 01/2020 providing Guidance on direct marketing. Political parties inviting their contacts to participate in political events. Context and Scope of Application. How to Comply? Necessity for a Clear Definition of Processing Purposes.

article thumbnail

Regulatory Update: NAIC Summer 2021 National Meeting

Data Matters

The amendment is consistent with Rule 18f-4 under the Securities and Exchange Commission (SEC) Investment Company Act of 1940 related to the use of derivatives by registered investment companies, including funds, which the SEC adopted in October 2020. If adopted, the accreditation standard would be effective for all states on January 1, 2026.